Showing results (361-370 of 1,154) with videos related to
Sort By:
Pageof 116
BMC Medicine|January 18, 2020
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirinMichael Berk, Mohammadreza Mohebbi, Olivia M Dean, et al.The American Journal of Psychiatry|March 17, 2021
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and ImplementationRoger S McIntyre, Joshua D Rosenblat, Charles B Nemeroff, et al.Inflammopharmacology|January 25, 2012
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitorsMichael Maes, Zdenĕk Fišar, Miguel Medina, et al.Journal of Affective Disorders|December 29, 2024
Psycho-biological mechanisms involved in suicidal risk, suicide attempts, and aggression: A replication and extension in bipolar disorderVahid Khosravani, Seyed Mehdi Samimi Ardestani, Michael Berk, et al.Clinical Psychology & Psychotherapy|October 15, 2024
The Connections Between Alexithymia, Childhood Maltreatment, Impulsivity and Extreme Sensory Processing Patterns in Relation to Bipolar Symptoms in Inpatients With Bipolar DisorderMorteza Aghaeimazraji, Vahid Khosravani, Seyed Mehdi Samimi Ardestani, et al.Social Psychiatry and Psychiatric Epidemiology|November 20, 2012
Diet quality and mental health problems in adolescents from East London: a prospective studyFelice N Jacka, Catherine Rothon, Stephanie Taylor, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|February 26, 2020
Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disordersGerwyn Morris, Michael Maes, Michael Berk, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 2020
The effect of combined treatment with SSRIs and renin-angiotensin system (RAS) drugs: A propensity score matched cohort studyOle Köhler-Forsberg, Liselotte Petersen, Michael Berk, et al.Molecular Neurobiology|June 25, 2016
Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue SyndromeGerwyn Morris, Michael Berk, Hans Klein, et al.Journal of Affective Disorders|January 10, 2021
The mental health and lifestyle impacts of COVID-19 on bipolar disorderJames A Karantonis, Susan L Rossell, Michael Berk, et al.Pageof 116